After nearly two years of review, the Food and Drug Administration (FDA) is preparing to deny Juul's application to keep its tobacco- and menthol-flavored vaping products on the market, according to reporting from The Wall Street Journal. The news is surprising; when compared to competitors' applications, Juul's was one of the most detailed and data-heavy, showing just how effective it was at transitioning smokers away from cigarettes, toward a safer alternative.
Research published in Nicotine and Tobacco Research that studied smokers who transitioned to Juuls found that smokers in North America were significantly more likely to switch to vaping than those in the United Kingdom who only had access to lower-strength nicotine products.
